Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The overall goal is to establish the safety and efficacy of colchicine in ICH patients for the prevention of major cardiovascular events and brain injury. Colchicine for the prevention of vascular events after an acute intracerebral hemorrhage (CoVasc-ICH) is a vanguard pilot trial designed to obtain the factual feasibility prerequisites essential for the planning, design, funding and execution of a subsequent phase III trial.
Epistemonikos ID: 3f6b583d76f719b5e877a05032429b895c995485
First added on: May 09, 2024